Results 221 to 230 of about 41,661 (291)

Long‐term outcomes of cribriform‐positive and cribriform‐negative prostate cancer treated with radical prostatectomy in the ProtecT trial

BJU International, Volume 137, Issue 6, Page 984-991, June 2026.
Objectives To retrospectively analyse the results of the Prostate Testing for Cancer and Treatment (ProtecT; ClinicalTrials.gov identifier: NCT02044172) trial to establish the association between cribriform‐positive and ‐negative prostate cancer (PCa) and the 15‐year risk of metastasis or death from PCa in patients who underwent radical prostatectomy ...
Nikita Sushentsev, Anne Y. Warren, Richard Colling, Clare Verrill, Ekaterina Pazukhina, Oleg Blyuss, Alexey Zaikin, Tyler M. Seibert, Tristan Barrett, Jon Oxley, Ian G. Mills, Richard J. Bryant, J. Athene Lane, Jenny L. Donovan, David E. Neal, Freddie C. Hamdy   +15 more
wiley   +1 more source

Postprostatectomy prostate cancer treated with radiation therapy: adverse features and androgen deprivation therapy use in a statewide consortium. [PDF]

JNCI Cancer Spectr
Regan SN, Dykstra M, Yin H, Mislmani M, Zaki M, McLaughlin P, Kendrick D, Miller S, Mietzel M, Borza T, Ginsberg K, Heimburger D, Morgan T, Schipper M, Jackson WC, Dess RT.   +15 more
europepmc   +1 more source

Exploring Lived Experiences of Men Diagnosed With Prostate Cancer in Oman: A Qualitative Study

Health Expectations, Volume 29, Issue 3, June 2026.
ABSTRACT Background Life after prostate cancer treatment may extend across decades; however, qualitative evidence describing how men in Oman navigate treatment sequelae, disclosure, family involvement, and religious coping remains limited. This study explored the lived experiences of Omani men who had completed primary therapy for prostate cancer ...
Khalood Al‐Abri, Mazin Hamood Al‐Louyahi, Hassan Said Al‐Samani, Mohammed Juma Al‐Ghanboosi, Khadem Hamed Al‐Junaibi, Nasser Hamood Al‐Adawi, Debby Syahru Romadlon   +6 more
wiley   +1 more source

Safety and efficacy of darolutamide in combination with androgen-deprivation therapy for prostate cancer: a systematic review and meta-analysis. [PDF]

Ann Med Surg (Lond)
Khan A, Akhter HAR, Rath S, Aslam R, Salamon I, Ali MA, Bashir M, Antar M, Muhibullah F.   +8 more
europepmc   +1 more source

β, β‐Dimethylacrylshikonin Triggers Caspase‐Mediated Cell Apoptosis via Heme Oxygenase‐1 Upregulation and ERK/p38 Activation in Prostate Cancer

Journal of Cellular and Molecular Medicine, Volume 30, Issue 11, June 2026.
ABSTRACT β, β‐Dimethylacrylshikonin (DMAS), a natural naphthoquinone derivative isolated from the root of a biennial herb belonging to the family Boraginaceae, has been demonstrated to exhibit anti‐cancer and anti‐inflammatory features. Yet, the effects of DMAS on restraining the progression of prostate cancer (PC) remain mostly elusive.
Wei‐Chun Weng, Yi‐Hsien Hsieh, Chih‐Hsin Tang, Shian‐Shiang Wang, Chun‐Chuan Su, Shih‐Chi Su, Shun‐Fa Yang   +6 more
wiley   +1 more source

Self-help cognitive behavioural therapy for hot flushes and night sweats during androgen deprivation therapy for prostate cancer: the MANCAN2 randomized controlled trial. [PDF]

Br J Cancer
Crabb SJ, Morgan A, Stefanopoulou E, Fleure L, Griffiths GO, Boxall C, Wilding S, Nearchou T, Ewings S, Nuttall J, Eminton Z, Tilt E, Whitby E, Siu B, Ridley P, Robson L, Nobes J, Preece J, Bacon R, Martin J, Chamberlain S, Fenlon D, Hunter M, Richardson A.   +23 more
europepmc   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Health inequities in pediatric anaphylaxis: A policy framework and call to action for equitable care from SIAIP allergy prevention commission

Pediatric Allergy and Immunology, Volume 37, Issue 6, June 2026.
Abstract Pediatric anaphylaxis is a rapidly evolving and potentially fatal allergic reaction whose incidence is increasing worldwide, particularly among young children. Despite international guidelines identifying intramuscular epinephrine as the first‐line, life‐saving treatment, significant health inequities persist in the prevention, recognition ...
Carolina Grella, Angela Klain, Amelia Licari, Sara Manti, Francesca Mori, Francesca Galletta, Antonio Andrea Senatore, Leonardo Tomei, Michele Miraglia del Giudice, Gian Luigi Marseglia, Cristiana Indolfi, The SIAIP Primary and Secondary Prevention of Allergic Diseases Commission   +11 more
wiley   +1 more source

TXNIP upregulation controls metabolism and cell cycle during androgen deprivation therapy in prostate cancer. [PDF]

Cell Death Dis
Alcon-Rodriguez S, Mayo JC, Gonzalez-Menendez P, Fernandez-Vega I, Hevia D, Fernandez-Vega S, Moran-Alvarez A, Pineda-Cevallos D, Alvarez-Mugica M, Rodriguez-Gonzalez P, Garcia-Soler B, Zamora J, Tubio JMC, Sainz RM, Quiros-Gonzalez I.   +14 more
europepmc   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source